早漏治療の世界市場 2024-2028

早漏治療市場は2023-2028年に14億5,985万米ドル、予測期間中のCAGRは8.78％で成長すると予測されています。

当レポートでは、早漏治療市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25社のベンダーを網羅したベンダー分析などを掲載しています。

当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、適応外（オフラベル）早漏治療薬の高い有効性、早漏治療に対する局所治療薬の需要増加、早漏を引き起こすリスク要因の増加によって牽引されています。

当レポートでは、早漏治療医薬品におけるナノテクノロジーの出現が、今後数年間の早漏治療市場成長を牽引する主要因の1つであるとしています。また、早漏治療に関連する研究開発の増加や、早漏治療用の新しいデバイスの出現が、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模 2023
• 市場の見通し 2023-2028

第4章 市場規模実績

• 世界の早漏治療市場 2018-2022
• 投与経路別セグメント分析 2018-2022
• 薬剤クラス別セグメント分析 2018-2022
• 地域別セグメント分析 2018-2022
• 国別セグメント分析 2018-2022

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：投与経路別

• 市場セグメント
• 比較：投与経路別
• 経口薬：市場規模と予測 2023-2028
• 局所薬：市場規模と予測 2023-2028
• 市場機会：投与経路別

第7章 市場セグメンテーション：薬剤クラス別

• 市場セグメント
• 比較：薬剤クラス別
• SSRI：市場規模と予測 2023-2028
• PDE5阻害剤：市場規模と予測 2023-2028
• アミド系麻酔薬：市場規模と予測 2023-2028
• その他：市場規模と予測 2023-2028
• 市場機会：薬剤クラス別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2023-2028
• 欧州：市場規模と予測 2023-2028
• アジア：市場規模と予測 2023-2028
• 世界のその他の地域：市場規模と予測 2023-2028
• 米国：市場規模と予測 2023-2028
• イタリア：市場規模と予測 2023-2028
• 中国：市場規模と予測 2023-2028
• 英国：市場規模と予測 2023-2028
• インド：市場規模と予測 2023-2028
• 市場機会：地域別

第10章 促進要因・課題・動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• A. Menarini Industrie Farmaceutiche Riunite Srl
• Absorption Pharmaceuticals LLC
• Alembic Pharmaceuticals Ltd.
• Amneal Pharmaceuticals Inc.
• Aytu BioPharma Inc.
• Bayer AG
• Eli Lilly and Co.
• Futura Medical plc
• GlaxoSmithKline Plc
• Johnson and Johnson
• LloydsPharmacy
• NeuroHealing Pharmaceuticals Inc.
• Pfizer Inc.
• Plethora Solutions Ltd.
• Veru Inc.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
• Exhibits6: Executive Summary - Chart on Market Segmentation by Drug Class
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits18: Historic Market Size - Data Table on global premature ejaculation treatment market 2018 - 2022 ($ million)
• Exhibits19: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
• Exhibits20: Historic Market Size - Drug Class Segment 2018 - 2022 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2023 and 2028
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits29: Chart on Market condition - Five forces 2023 and 2028
• Exhibits30: Chart on Route of Administration - Market share 2023-2028 (%)
• Exhibits31: Data Table on Route of Administration - Market share 2023-2028 (%)
• Exhibits32: Chart on Comparison by Route of Administration
• Exhibits33: Data Table on Comparison by Route of Administration
• Exhibits34: Chart on Oral - Market size and forecast 2023-2028 ($ million)
• Exhibits35: Data Table on Oral - Market size and forecast 2023-2028 ($ million)
• Exhibits36: Chart on Oral - Year-over-year growth 2023-2028 (%)
• Exhibits37: Data Table on Oral - Year-over-year growth 2023-2028 (%)
• Exhibits38: Chart on Topical - Market size and forecast 2023-2028 ($ million)
• Exhibits39: Data Table on Topical - Market size and forecast 2023-2028 ($ million)
• Exhibits40: Chart on Topical - Year-over-year growth 2023-2028 (%)
• Exhibits41: Data Table on Topical - Year-over-year growth 2023-2028 (%)
• Exhibits42: Market opportunity by Route of Administration ($ million)
• Exhibits43: Data Table on Market opportunity by Route of Administration ($ million)
• Exhibits44: Chart on Drug Class - Market share 2023-2028 (%)
• Exhibits45: Data Table on Drug Class - Market share 2023-2028 (%)
• Exhibits46: Chart on Comparison by Drug Class
• Exhibits47: Data Table on Comparison by Drug Class
• Exhibits48: Chart on SSRIs - Market size and forecast 2023-2028 ($ million)
• Exhibits49: Data Table on SSRIs - Market size and forecast 2023-2028 ($ million)
• Exhibits50: Chart on SSRIs - Year-over-year growth 2023-2028 (%)
• Exhibits51: Data Table on SSRIs - Year-over-year growth 2023-2028 (%)
• Exhibits52: Chart on PDE5 inhibitors - Market size and forecast 2023-2028 ($ million)
• Exhibits53: Data Table on PDE5 inhibitors - Market size and forecast 2023-2028 ($ million)
• Exhibits54: Chart on PDE5 inhibitors - Year-over-year growth 2023-2028 (%)
• Exhibits55: Data Table on PDE5 inhibitors - Year-over-year growth 2023-2028 (%)
• Exhibits56: Chart on Amide anesthetics - Market size and forecast 2023-2028 ($ million)
• Exhibits57: Data Table on Amide anesthetics - Market size and forecast 2023-2028 ($ million)
• Exhibits58: Chart on Amide anesthetics - Year-over-year growth 2023-2028 (%)
• Exhibits59: Data Table on Amide anesthetics - Year-over-year growth 2023-2028 (%)
• Exhibits60: Chart on Others - Market size and forecast 2023-2028 ($ million)
• Exhibits61: Data Table on Others - Market size and forecast 2023-2028 ($ million)
• Exhibits62: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibits63: Data Table on Others - Year-over-year growth 2023-2028 (%)
• Exhibits64: Market opportunity by Drug Class ($ million)
• Exhibits65: Data Table on Market opportunity by Drug Class ($ million)
• Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits67: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits69: Chart on Geographic comparison
• Exhibits70: Data Table on Geographic comparison
• Exhibits71: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits73: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits74: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits77: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits81: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits87: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibits88: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibits89: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits90: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits91: Chart on Italy - Market size and forecast 2023-2028 ($ million)
• Exhibits92: Data Table on Italy - Market size and forecast 2023-2028 ($ million)
• Exhibits93: Chart on Italy - Year-over-year growth 2023-2028 (%)
• Exhibits94: Data Table on Italy - Year-over-year growth 2023-2028 (%)
• Exhibits95: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibits96: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibits97: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibits98: Data Table on China - Year-over-year growth 2023-2028 (%)
• Exhibits99: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits100: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits101: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits102: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits103: Chart on India - Market size and forecast 2023-2028 ($ million)
• Exhibits104: Data Table on India - Market size and forecast 2023-2028 ($ million)
• Exhibits105: Chart on India - Year-over-year growth 2023-2028 (%)
• Exhibits106: Data Table on India - Year-over-year growth 2023-2028 (%)
• Exhibits107: Market opportunity By Geographical Landscape ($ million)
• Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million)
• Exhibits109: Impact of drivers and challenges in 2023 and 2028
• Exhibits110: Overview on Criticality of inputs and Factors of differentiation
• Exhibits111: Overview on factors of disruption
• Exhibits112: Impact of key risks on business
• Exhibits113: Vendors covered
• Exhibits114: Matrix on vendor position and classification
• Exhibits115: A. Menarini Industrie Farmaceutiche Riunite Srl - Overview
• Exhibits116: A. Menarini Industrie Farmaceutiche Riunite Srl - Product / Service
• Exhibits117: A. Menarini Industrie Farmaceutiche Riunite Srl - Key offerings
• Exhibits118: Absorption Pharmaceuticals LLC - Overview
• Exhibits119: Absorption Pharmaceuticals LLC - Product / Service
• Exhibits120: Absorption Pharmaceuticals LLC - Key offerings
• Exhibits121: Alembic Pharmaceuticals Ltd. - Overview
• Exhibits122: Alembic Pharmaceuticals Ltd. - Product / Service
• Exhibits123: Alembic Pharmaceuticals Ltd. - Key offerings
• Exhibits124: Amneal Pharmaceuticals Inc. - Overview
• Exhibits125: Amneal Pharmaceuticals Inc. - Business segments
• Exhibits126: Amneal Pharmaceuticals Inc. - Key news
• Exhibits127: Amneal Pharmaceuticals Inc. - Key offerings
• Exhibits128: Amneal Pharmaceuticals Inc. - Segment focus
• Exhibits129: Aytu BioPharma Inc. - Overview
• Exhibits130: Aytu BioPharma Inc. - Product / Service
• Exhibits131: Aytu BioPharma Inc. - Key offerings
• Exhibits132: Bayer AG - Overview
• Exhibits133: Bayer AG - Business segments
• Exhibits134: Bayer AG - Key news
• Exhibits135: Bayer AG - Key offerings
• Exhibits136: Bayer AG - Segment focus
• Exhibits137: Eli Lilly and Co. - Overview
• Exhibits138: Eli Lilly and Co. - Product / Service
• Exhibits139: Eli Lilly and Co. - Key news
• Exhibits140: Eli Lilly and Co. - Key offerings
• Exhibits141: Futura Medical plc - Overview
• Exhibits142: Futura Medical plc - Product / Service
• Exhibits143: Futura Medical plc - Key offerings
• Exhibits144: GlaxoSmithKline Plc - Overview
• Exhibits145: GlaxoSmithKline Plc - Business segments
• Exhibits146: GlaxoSmithKline Plc - Key news
• Exhibits147: GlaxoSmithKline Plc - Key offerings
• Exhibits148: GlaxoSmithKline Plc - Segment focus
• Exhibits149: Johnson and Johnson - Overview
• Exhibits150: Johnson and Johnson - Business segments
• Exhibits151: Johnson and Johnson - Key news
• Exhibits152: Johnson and Johnson - Key offerings
• Exhibits153: Johnson and Johnson - Segment focus
• Exhibits154: LloydsPharmacy - Overview
• Exhibits155: LloydsPharmacy - Product / Service
• Exhibits156: LloydsPharmacy - Key offerings
• Exhibits157: NeuroHealing Pharmaceuticals Inc. - Overview
• Exhibits158: NeuroHealing Pharmaceuticals Inc. - Product / Service
• Exhibits159: NeuroHealing Pharmaceuticals Inc. - Key offerings
• Exhibits160: Pfizer Inc. - Overview
• Exhibits161: Pfizer Inc. - Product / Service
• Exhibits162: Pfizer Inc. - Key news
• Exhibits163: Pfizer Inc. - Key offerings
• Exhibits164: Plethora Solutions Ltd. - Overview
• Exhibits165: Plethora Solutions Ltd. - Product / Service
• Exhibits166: Plethora Solutions Ltd. - Key offerings
• Exhibits167: Veru Inc. - Overview
• Exhibits168: Veru Inc. - Business segments
• Exhibits169: Veru Inc. - Key offerings
• Exhibits170: Veru Inc. - Segment focus
• Exhibits171: Inclusions checklist
• Exhibits172: Exclusions checklist
• Exhibits173: Currency conversion rates for US$
• Exhibits174: Research methodology
• Exhibits175: Validation techniques employed for market sizing
• Exhibits176: Information sources
• Exhibits177: List of abbreviations

The premature ejaculation treatment market is forecasted to grow by USD 1459.85 mn during 2023-2028, accelerating at a CAGR of 8.78% during the forecast period. The report on the premature ejaculation treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high efficacy of off-label premature ejaculation drugs, increasing demand for topical drug therapies for premature ejaculation treatment, and growing risk factors causing premature ejaculation.

Technavio's premature ejaculation treatment market is segmented as below:

By Route Of Administration

• Oral
• Topical

By Drug Class

• SSRIs
• PDE5 inhibitors
• Amide anesthetics
• Others

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the advent of nanotechnology in premature ejaculation treatment drugs as one of the prime reasons driving the premature ejaculation treatment market growth during the next few years. Also, increasing research and development related to premature ejaculation treatments and emergence of novel devices for premature ejaculation treatments will lead to sizable demand in the market.

The report on the premature ejaculation treatment market covers the following areas:

• Premature ejaculation treatment market sizing
• Premature ejaculation treatment market forecast
• Premature ejaculation treatment market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading premature ejaculation treatment market vendors that include A. Menarini Industrie Farmaceutiche Riunite Srl, Absorption Pharmaceuticals LLC, Alembic Pharmaceuticals Ltd., Amneal Pharmaceuticals Inc., Aytu BioPharma Inc., Bayer AG, Eli Lilly and Co., Futura Medical plc, GlaxoSmithKline Plc, Johnson and Johnson, LloydsPharmacy, Morari Inc., NeuroHealing Pharmaceuticals Inc., Niksan Pharmaceutical, Pfizer Inc., Plethora Solutions Ltd., Prinston Pharmaceutical Inc., Ralington Pharma LLP, Sunrise Remedies Pvt. Ltd., Tabuk Pharmaceuticals, Veru Inc., and VIVUS LLC. Also, the premature ejaculation treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Drug Class
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global premature ejaculation treatment market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global premature ejaculation treatment market 2018 - 2022 ($ million)
• 4.2 Route of Administration Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
• 4.3 Drug Class Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - Drug Class Segment 2018 - 2022 ($ million)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Route of Administration

• 6.1 Market segments
• Exhibit 30: Chart on Route of Administration - Market share 2023-2028 (%)
• Exhibit 31: Data Table on Route of Administration - Market share 2023-2028 (%)
• 6.2 Comparison by Route of Administration
• Exhibit 32: Chart on Comparison by Route of Administration
• Exhibit 33: Data Table on Comparison by Route of Administration
• 6.3 Oral - Market size and forecast 2023-2028
• Exhibit 34: Chart on Oral - Market size and forecast 2023-2028 ($ million)
• Exhibit 35: Data Table on Oral - Market size and forecast 2023-2028 ($ million)
• Exhibit 36: Chart on Oral - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on Oral - Year-over-year growth 2023-2028 (%)
• 6.4 Topical - Market size and forecast 2023-2028
• Exhibit 38: Chart on Topical - Market size and forecast 2023-2028 ($ million)
• Exhibit 39: Data Table on Topical - Market size and forecast 2023-2028 ($ million)
• Exhibit 40: Chart on Topical - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on Topical - Year-over-year growth 2023-2028 (%)
• 6.5 Market opportunity by Route of Administration
• Exhibit 42: Market opportunity by Route of Administration ($ million)
• Exhibit 43: Data Table on Market opportunity by Route of Administration ($ million)

7 Market Segmentation by Drug Class

• 7.1 Market segments
• Exhibit 44: Chart on Drug Class - Market share 2023-2028 (%)
• Exhibit 45: Data Table on Drug Class - Market share 2023-2028 (%)
• 7.2 Comparison by Drug Class
• Exhibit 46: Chart on Comparison by Drug Class
• Exhibit 47: Data Table on Comparison by Drug Class
• 7.3 SSRIs - Market size and forecast 2023-2028
• Exhibit 48: Chart on SSRIs - Market size and forecast 2023-2028 ($ million)
• Exhibit 49: Data Table on SSRIs - Market size and forecast 2023-2028 ($ million)
• Exhibit 50: Chart on SSRIs - Year-over-year growth 2023-2028 (%)
• Exhibit 51: Data Table on SSRIs - Year-over-year growth 2023-2028 (%)
• 7.4 PDE5 inhibitors - Market size and forecast 2023-2028
• Exhibit 52: Chart on PDE5 inhibitors - Market size and forecast 2023-2028 ($ million)
• Exhibit 53: Data Table on PDE5 inhibitors - Market size and forecast 2023-2028 ($ million)
• Exhibit 54: Chart on PDE5 inhibitors - Year-over-year growth 2023-2028 (%)
• Exhibit 55: Data Table on PDE5 inhibitors - Year-over-year growth 2023-2028 (%)
• 7.5 Amide anesthetics - Market size and forecast 2023-2028
• Exhibit 56: Chart on Amide anesthetics - Market size and forecast 2023-2028 ($ million)
• Exhibit 57: Data Table on Amide anesthetics - Market size and forecast 2023-2028 ($ million)
• Exhibit 58: Chart on Amide anesthetics - Year-over-year growth 2023-2028 (%)
• Exhibit 59: Data Table on Amide anesthetics - Year-over-year growth 2023-2028 (%)
• 7.6 Others - Market size and forecast 2023-2028
• Exhibit 60: Chart on Others - Market size and forecast 2023-2028 ($ million)
• Exhibit 61: Data Table on Others - Market size and forecast 2023-2028 ($ million)
• Exhibit 62: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibit 63: Data Table on Others - Year-over-year growth 2023-2028 (%)
• 7.7 Market opportunity by Drug Class
• Exhibit 64: Market opportunity by Drug Class ($ million)
• Exhibit 65: Data Table on Market opportunity by Drug Class ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 69: Chart on Geographic comparison
• Exhibit 70: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
• Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
• Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
• Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 Italy - Market size and forecast 2023-2028
• Exhibit 91: Chart on Italy - Market size and forecast 2023-2028 ($ million)
• Exhibit 92: Data Table on Italy - Market size and forecast 2023-2028 ($ million)
• Exhibit 93: Chart on Italy - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on Italy - Year-over-year growth 2023-2028 (%)
• 9.9 China - Market size and forecast 2023-2028
• Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.10 UK - Market size and forecast 2023-2028
• Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%)
• 9.11 India - Market size and forecast 2023-2028
• Exhibit 103: Chart on India - Market size and forecast 2023-2028 ($ million)
• Exhibit 104: Data Table on India - Market size and forecast 2023-2028 ($ million)
• Exhibit 105: Chart on India - Year-over-year growth 2023-2028 (%)
• Exhibit 106: Data Table on India - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 107: Market opportunity By Geographical Landscape ($ million)
• Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 109: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 111: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 112: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 113: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 114: Matrix on vendor position and classification
• 12.3 A. Menarini Industrie Farmaceutiche Riunite Srl
• Exhibit 115: A. Menarini Industrie Farmaceutiche Riunite Srl - Overview
• Exhibit 116: A. Menarini Industrie Farmaceutiche Riunite Srl - Product / Service
• Exhibit 117: A. Menarini Industrie Farmaceutiche Riunite Srl - Key offerings
• 12.4 Absorption Pharmaceuticals LLC
• Exhibit 118: Absorption Pharmaceuticals LLC - Overview
• Exhibit 119: Absorption Pharmaceuticals LLC - Product / Service
• Exhibit 120: Absorption Pharmaceuticals LLC - Key offerings
• 12.5 Alembic Pharmaceuticals Ltd.
• Exhibit 121: Alembic Pharmaceuticals Ltd. - Overview
• Exhibit 122: Alembic Pharmaceuticals Ltd. - Product / Service
• Exhibit 123: Alembic Pharmaceuticals Ltd. - Key offerings
• 12.6 Amneal Pharmaceuticals Inc.
• Exhibit 124: Amneal Pharmaceuticals Inc. - Overview
• Exhibit 125: Amneal Pharmaceuticals Inc. - Business segments
• Exhibit 126: Amneal Pharmaceuticals Inc. - Key news
• Exhibit 127: Amneal Pharmaceuticals Inc. - Key offerings
• Exhibit 128: Amneal Pharmaceuticals Inc. - Segment focus
• 12.7 Aytu BioPharma Inc.
• Exhibit 129: Aytu BioPharma Inc. - Overview
• Exhibit 130: Aytu BioPharma Inc. - Product / Service
• Exhibit 131: Aytu BioPharma Inc. - Key offerings
• 12.8 Bayer AG
• Exhibit 132: Bayer AG - Overview
• Exhibit 133: Bayer AG - Business segments
• Exhibit 134: Bayer AG - Key news
• Exhibit 135: Bayer AG - Key offerings
• Exhibit 136: Bayer AG - Segment focus
• 12.9 Eli Lilly and Co.
• Exhibit 137: Eli Lilly and Co. - Overview
• Exhibit 138: Eli Lilly and Co. - Product / Service
• Exhibit 139: Eli Lilly and Co. - Key news
• Exhibit 140: Eli Lilly and Co. - Key offerings
• 12.10 Futura Medical plc
• Exhibit 141: Futura Medical plc - Overview
• Exhibit 142: Futura Medical plc - Product / Service
• Exhibit 143: Futura Medical plc - Key offerings
• 12.11 GlaxoSmithKline Plc
• Exhibit 144: GlaxoSmithKline Plc - Overview
• Exhibit 145: GlaxoSmithKline Plc - Business segments
• Exhibit 146: GlaxoSmithKline Plc - Key news
• Exhibit 147: GlaxoSmithKline Plc - Key offerings
• Exhibit 148: GlaxoSmithKline Plc - Segment focus
• 12.12 Johnson and Johnson
• Exhibit 149: Johnson and Johnson - Overview
• Exhibit 150: Johnson and Johnson - Business segments
• Exhibit 151: Johnson and Johnson - Key news
• Exhibit 152: Johnson and Johnson - Key offerings
• Exhibit 153: Johnson and Johnson - Segment focus
• 12.13 LloydsPharmacy
• Exhibit 154: LloydsPharmacy - Overview
• Exhibit 155: LloydsPharmacy - Product / Service
• Exhibit 156: LloydsPharmacy - Key offerings
• 12.14 NeuroHealing Pharmaceuticals Inc.
• Exhibit 157: NeuroHealing Pharmaceuticals Inc. - Overview
• Exhibit 158: NeuroHealing Pharmaceuticals Inc. - Product / Service
• Exhibit 159: NeuroHealing Pharmaceuticals Inc. - Key offerings
• 12.15 Pfizer Inc.
• Exhibit 160: Pfizer Inc. - Overview
• Exhibit 161: Pfizer Inc. - Product / Service
• Exhibit 162: Pfizer Inc. - Key news
• Exhibit 163: Pfizer Inc. - Key offerings
• 12.16 Plethora Solutions Ltd.
• Exhibit 164: Plethora Solutions Ltd. - Overview
• Exhibit 165: Plethora Solutions Ltd. - Product / Service
• Exhibit 166: Plethora Solutions Ltd. - Key offerings
• 12.17 Veru Inc.
• Exhibit 167: Veru Inc. - Overview
• Exhibit 168: Veru Inc. - Business segments
• Exhibit 169: Veru Inc. - Key offerings
• Exhibit 170: Veru Inc. - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 171: Inclusions checklist
• Exhibit 172: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 173: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 174: Research methodology
• Exhibit 175: Validation techniques employed for market sizing
• Exhibit 176: Information sources
• 13.5 List of abbreviations
• Exhibit 177: List of abbreviations